|
|
Line 78: |
Line 78: |
| Use 200 μM of each dNTP. Do not use dUTP. | | Use 200 μM of each dNTP. Do not use dUTP. |
| | | |
- | 4.4 Template | + | <b>Cycling Program</b> |
| + | |
| + | (3 step protocol) |
| + | |
| + | {| |
| + | |Cycle step |
| + | |Temp. |
| + | |Time |
| + | |Cycles |
| + | |- |
| + | |Initial denaturation |
| + | |98°C |
| + | |30 s |
| + | |1 |
| + | |- |
| + | |Denaturation |
| + | |98°C |
| + | |5–10 s |
| + | | |
| + | |- |
| + | |Annealing (see 5) |
| + | |X°C |
| + | |10–30 s |
| + | |25-30 |
| + | |- |
| + | |Extension |
| + | |72°C |
| + | |15–30 s/kb |
| + | | |
| + | |- |
| + | |Final extension |
| + | |72°C |
| + | |5–10 min |
| + | |1 |
| + | |- |
| + | |Pause |
| + | |4°C |
| + | |hold |
| + | | |
| + | |- |
| + | |} |
| + | |
| + | <b>4.4 Template</b> |
| + | |
| General guidelines for low complexity DNA (e.g. plasmid, | | General guidelines for low complexity DNA (e.g. plasmid, |
| lambda or BAC DNA) are: 1 pg–10 ng per 50 μl reaction | | lambda or BAC DNA) are: 1 pg–10 ng per 50 μl reaction |
Line 86: |
Line 129: |
| of template, the volume of the template should not exceed | | of template, the volume of the template should not exceed |
| 10 % of the final PCR reaction volume. | | 10 % of the final PCR reaction volume. |
- | 4.5 PCR additives | + | |
| + | <b>4.5 PCR additives</b> |
| + | |
| The recommended reaction conditions for GC-rich templates | | The recommended reaction conditions for GC-rich templates |
| include 3 % DMSO as a PCR additive, which aids in the | | include 3 % DMSO as a PCR additive, which aids in the |
Line 95: |
Line 140: |
| (up to 3 %), glycerol and betaine are also compatible with | | (up to 3 %), glycerol and betaine are also compatible with |
| Phusion Hot Start II DNA Polymerase. | | Phusion Hot Start II DNA Polymerase. |
| + | |
| If high DMSO concentration is used, the annealing | | If high DMSO concentration is used, the annealing |
| temperature must be decreased, as DMSO affects the melting | | temperature must be decreased, as DMSO affects the melting |
Line 100: |
Line 146: |
| decreases the annealing temperature by 5.5–6.0°C4. | | decreases the annealing temperature by 5.5–6.0°C4. |
| | | |
- | 5. Notes about cycling conditions | + | <b>5. Notes about cycling conditions</b> |
- | 5.1 Initial denaturation
| + | |
- | Denaturation should be performed at 98°C. Due to the high | + | Denaturation should be performed at 98°C. |
- | thermostability of Phusion Hot Start II DNA Polymerase even
| + | |
- | higher than 98°C denaturation temperatures can be used.
| + | |
- | We recommend a 30-second initial denaturation at 98°C for
| + | |
- | most templates. Some templates may require longer initial
| + | |
- | denaturation time, and the length of the initial denaturation
| + | |
- | time can be extended up to 3 minutes.
| + | |
- | 5.2 Denaturation
| + | |
| Keep the denaturation time as short as possible. Usually 5–10 | | Keep the denaturation time as short as possible. Usually 5–10 |
- | seconds at 98°C is enough for most templates. Note: the | + | seconds at 98°C is enough for most templates. |
- | denaturation time and temperature may vary depending on
| + | |
- | the ramp rate and temperature control mode of the cycler.
| + | |
- | 5.3 Primer annealing
| + | |
| The optimal annealing temperature for Phusion Hot Start II | | The optimal annealing temperature for Phusion Hot Start II |
| DNA Polymerase may differ significantly from that of Taq-based | | DNA Polymerase may differ significantly from that of Taq-based |
Line 120: |
Line 158: |
| on Finnzymes’ website (www.finnzymes.com) to determine | | on Finnzymes’ website (www.finnzymes.com) to determine |
| the Tm values of primers and optimal annealing temperature. | | the Tm values of primers and optimal annealing temperature. |
| + | |
| As a basic rule, for primers >20 nt, anneal for 10–30 seconds | | As a basic rule, for primers >20 nt, anneal for 10–30 seconds |
- | at a Tm +3°C of the lower Tm primer. For primers ≤ 20 nt, | + | at a Tm +3°C of the lower Tm primer. |
- | Cycle step
| + | |
- | 2-step protocol 3-step protocol
| + | |
- | Temp. Time Temp. Time Cycles
| + | |
- | Initial denaturation 98°C 30 s 98°C 30 s 1
| + | |
- | Denaturation
| + | |
- | Annealing (see 5.3)
| + | |
- | Extension (see 5.4)
| + | |
- | 98°C
| + | |
- | –
| + | |
- | 72°C
| + | |
- | 5–10 s
| + | |
- | –
| + | |
- | 15–30 s/kb
| + | |
- | 98°C
| + | |
- | X°C
| + | |
- | 72°C
| + | |
- | 5–10 s
| + | |
- | 10–30 s
| + | |
- | 15–30 s/kb
| + | |
- | 25–35
| + | |
- | Final extension
| + | |
- | 72°C
| + | |
- | 4°C
| + | |
- | 5–10 min
| + | |
- | hold
| + | |
- | 72°C
| + | |
- | 4°C
| + | |
- | 5–10 min
| + | |
- | hold
| + | |
- | 1
| + | |
- | use an annealing temperature equal to the Tm of the lower
| + | |
- | Tm primer. If necessary, use a temperature gradient to find
| + | |
- | the optimal annealing temperature for each template-primer
| + | |
- | pair combination. The annealing gradient should extend up to
| + | |
- | the extension temperature (two-step PCR). A 2-step protocol
| + | |
- | is recommended when primer Tm values are at least 69°C (>
| + | |
- | 20 nt) or 72°C (≤ 20 nt) when calculated with Finnzymes’ Tm
| + | |
- | calculator. In the 2-step protocol the combined annealing/
| + | |
- | extension step should be performed at 72°C even when the
| + | |
- | primer Tm is > 72°C.
| + | |
- | 5.4 Extension
| + | |
- | The extension should be performed at 72°C. The extension time
| + | |
- | depends on the length and complexity of the amplicon. For
| + | |
- | low complexity DNA (e.g. plasmid, lambda or BAC DNA) use
| + | |
- | an extension time of 15 seconds per 1 kb. For high complexity
| + | |
- | genomic DNA, 30 seconds per 1 kb is recommended. For some
| + | |
- | cDNA templates, the extension time can be increased up to 40
| + | |
- | seconds per 1 kb to obtain optimal results.
| + | |
- | 6. Troubleshooting
| + | |
- | 7. Component specifications
| + | |
- | 7.1 Phusion® Hot Start II High-Fidelity DNA
| + | |
- | Polymerase (F-549)
| + | |
- | Thermostable Phusion DNA Polymerase is isolated and
| + | |
- | purified from an E. coli strain expressing the cloned Phusion
| + | |
- | DNA Polymerase gene. Phusion DNA Polymerase possesses
| + | |
- | the following activities: 5´→3´ DNA polymerase activity and
| + | |
- | 3´→5´ exonuclease activity. The Affibody ligand is isolated and
| + | |
- | purified from an E. coli strain expressing the cloned Affibodyencoding
| + | |
- | gene. Phusion Hot Start II DNA Polymerase is free of
| + | |
- | contaminating endo- and exonucleases.
| + | |
- | Storage buffer: 20 mM Tris-HCl (pH 7.4 at 25°C), 0.1 mM
| + | |
- | EDTA, 1 mM DTT, 100 mM KCl, stabilizers, 200 μg/ml BSA
| + | |
- | and 50 % glycerol.
| + | |
- | Unit definition: One unit is defined as the amount of enzyme
| + | |
- | that will incorporate 10 nmoles of dNTPs into acid-insoluble
| + | |
- | form at 74°C in 30 minutes under the stated assay conditions.
| + | |
- | Unit assay conditions: Incubation buffer: 25 mM TAPSHCl,
| + | |
- | pH 9.3 (at 25°C), 50 mM KCl, 2 mM MgCl2, 1 mM
| + | |
- | β-mercaptoethanol, 100 μM dCTP, 200 μM each dATP, dGTP,
| + | |
- | dTTP.
| + | |
- | Incubation procedure: 20 μg activated calf thymus DNA
| + | |
- | and 0.5 μCi [α-32P] dCTP are incubated with 0.1 units of
| + | |
- | DNA polymerase in 50 μl incubation buffer at 74°C for
| + | |
- | 10 minutes. The amount of incorporated dNTPs is determined
| + | |
- | by trichloroacetic acid precipitation.
| + | |
- | DNA amplification test: Performance in PCR is tested by the
| + | |
- | amplification of 2.3 and 7.5 kb genomic DNA and 20 kb
| + | |
- | λ DNA.
| + | |
- | Exonuclease contamination assay: Incubation of 10 U for 4
| + | |
- | hours at 72°C in 50 μl assay buffer with 1 μg sonicated [3H] DNA
| + | |
- | (2 x 105 cpm/μg) released < 1 % of radioactivity.
| + | |
- | Endonuclease contamination assay: No endonuclease activity was
| + | |
- | observed after incubation of 10 U of DNA polymerase with 1 μg of
| + | |
- | λ DNA in assay buffer at 72°C for 4 hours.
| + | |
- | 7.2 5x Phusion® HF Buffer (F-518)
| + | |
- | The 5x Phusion HF Buffer contains 7.5 mM MgCl2, which
| + | |
- | provides 1.5 mM MgCl2 in final reaction conditions.
| + | |
- | 7.3 5x Phusion® GC Buffer (F-519)
| + | |
- | The 5x Phusion GC Buffer contains 7.5 mM MgCl2, which
| + | |
- | provides 1.5 mM MgCl2 in final reaction conditions.
| + | |
- | Caution: Repeated freezing and thawing of the buffer can result
| + | |
- | in the precipitation or accumulation of MgCl2 in insoluble form.
| + | |
- | For consistent results, heat the buffer to 90°C for 10 min and
| + | |
- | vortex prior to use if needed, or store refrigerated.
| + | |
- | 7.4 50 mM MgCl2 Solution (F-510MG)
| + | |
- | Both Phusion Buffers supply 1.5 mM MgCl2 at final reaction
| + | |
- | conditions. If higher MgCl2 concentrations are desired, use a
| + | |
- | 50 mM MgCl2 solution to increase the MgCl2 titer. Using the
| + | |
- | following equation, you can calculate the volume of 50 mM
| + | |
- | MgCl2 needed to attain the final MgCl2 concentration: [desired
| + | |
- | mM Mg] – [1.5 mM] = μl to add to a 50 μl reaction.
| + | |
- | For example to increase the MgCl2 concentration to
| + | |
- | 2.0 mM, add 0.5 μl of the 50 mM MgCl2 solution. Because the
| + | |
- | No product at all or low yield
| + | |
- | • Repeat the PCR and make sure that there are no pipetting errors.
| + | |
- | • Use Finnzymes’ Tm calculator (www.finnzymes.com).
| + | |
- | • Use fresh high-quality dNTPs.
| + | |
- | • Do not use dNTP mix or primers that contain dUTP or dITP.
| + | |
- | • Sample concentration may be too low. Use more template.
| + | |
- | • Template DNA may be damaged. Use carefully purified template.
| + | |
- | • Increase extension time.
| + | |
- | • Increase the number of cycles.
| + | |
- | • Decrease annealing temperature.
| + | |
- | • Optimize enzyme concentration.
| + | |
- | • Titrate DMSO (2–8 %) in the reaction (see section 4.5).
| + | |
- | • Denaturation temperature may be too low. Optimal denaturation
| + | |
- | temperature for most templates is 98°C or higher.
| + | |
- | • Denaturation time may be too long or too short.
| + | |
- | Optimize denaturation time.
| + | |
- | • Check the purity and concentration of the primers.
| + | |
- | • Check primer design.
| + | |
- | • Try using the alternative GC Buffer (see section 4.2).
| + | |
- | Non-specific products - High molecular weight smears
| + | |
- | • Decrease enzyme concentration (see section 4.1).
| + | |
- | • Decrease extension time (see section 5.4).
| + | |
- | • Reduce the total number of cycles.
| + | |
- | • Increase annealing temperature or try 2-step protocol (see section
| + | |
- | 5.3).
| + | |
- | • Vary denaturation temperature (see section 5.2).
| + | |
- | • Optimize Mg2+ concentration (see section 4.3).
| + | |
- | • Reduce primer concentration.
| + | |
- | Non-specific products - Low molecular weight discrete bands
| + | |
- | • Increase annealing temperature (see section 5.3).
| + | |
- | • Shorten extension time (see section 5.4).
| + | |
- | • Reduce enzyme concentration (see section 4.1).
| + | |
- | • Optimize Mg2+ concentration (see section 4.3).
| + | |
- | • Titrate template amount.
| + | |
- | • Decrease primer concentration.
| + | |
- | • Design new primers.
| + | |
- | PCR reactions can be quite sensitive to changes in the MgCl2
| + | |
- | concentration, it is recommended that the 50 mM MgCl2
| + | |
- | stock solution is diluted 1:5 (to 10 mM) to minimize pipetting
| + | |
- | errors.
| + | |
- | 8. References
| + | |
- | 1. Frey M. & Suppmann B. (1995) Biochemica 2: 34–35.
| + | |
- | 2. Nord K. et al. (1997) Nature Biotechnol. 15: 772–777.
| + | |
- | 3. Wikman M. et al. (2004) Protein Eng. Des. Sel. 17: 455–
| + | |
- | 462.
| + | |
- | 4. Chester N. & Marshak D.R. (1993) Anal. Biochem. 209:
| + | |
- | 284–290.
| + | |
- | Shipping and storage
| + | |
- | Phusion Hot Start II DNA Polymerase is shipped on gel ice.
| + | |
- | Upon arrival, store the components at −20°C. Phusion Hot
| + | |
- | Start II DNA Polymerase is stable for one year from the assay
| + | |
- | date when stored and handled properly.
| + | |
- | Warranty
| + | |
- | Finnzymes Oy warrants that its products will meet the specifications stated on the technical
| + | |
- | data section of the data sheets, and Finnzymes Oy agrees to replace the products free of
| + | |
- | charge if the products do not conform to the specifications. Notice for replacement must be
| + | |
- | given within 60 days of receipt. In consideration of the above commitments by Finnzymes
| + | |
- | Oy, the buyer agrees to and accepts the following conditions:
| + | |
- | • That this warranty is in lieu of all other warranties, express or implied;
| + | |
- | • That ALL WARRANTIES OF MERCHANTABILITY OR OF FITNESS FOR A PARTICULAR
| + | |
- | PURPOSE ARE HEREBY EXCLUDED AND WAIVED;
| + | |
- | • That the buyer’s sole remedy shall be to obtain replacement of the product free of charge
| + | |
- | from Finnzymes Oy; and
| + | |
- | • That this remedy is in lieu of all other remedies or claims for damages, consequential or
| + | |
- | otherwise, which the buyer may have against Finnzymes Oy.
| + | |
- | Exclusive terms of sale
| + | |
- | Finnzymes Oy does not agree to and is not bound by any other terms or conditions, unless
| + | |
- | those terms and conditions have been expressly agreed to in writing by a duly authorised
| + | |
- | officer of Finnzymes Oy. Prices are subject to change without notice.
| + | |
- | Recommended guidelines for safe use of the products
| + | |
- | Finnzymes Oy recommends that the buyer and other persons using the products follow the
| + | |
- | Guidelines for Research involving Recombinant DNA Molecules (NIH guidelines) Federal
| + | |
- | Register, July 5, 1994 (59 FR 34496) and any amendments thereto. Finnzymes Oy disclaims
| + | |
- | any and all responsibility for any injury or damage which may be caused by the failure of
| + | |
- | the buyer or any other person to follow said guidelines.
| + | |
- | Research use only
| + | |
- | Since these products are intended for research purposes by qualified persons, the
| + | |
- | Environmental Protection Agency does not require us to supply Premanufacturing Notice.
| + | |
- | Notice to user
| + | |
- | The information presented here is accurate and reliable to the best of our knowledge and
| + | |
- | belief, but is not guaranteed to be so. Nothing herein is to be construed as recommending any
| + | |
- | practice or any product in violation of any patent or in violation of any law or regulation. It is
| + | |
- | the user’s responsibility to determine for himself or herself the suitability of any material and/or
| + | |
- | procedure for a specific purpose and to adopt such safety precautions as may be necessary.
| + | |
- | Notice to Purchaser of Phusion® DNA Polymerases:
| + | |
- | Limited license (proofreading DNA polymerases)
| + | |
- | The purchase price of this product includes a limited, non-transferable license under U.S. and
| + | |
- | foreign patents (5,500,363 and 5,352,778) owned by New England Biolabs, Inc. to use this
| + | |
- | product. No other license under these patents is conveyed expressly or by implication to the
| + | |
- | purchaser by the purchase of this product.
| + | |
- | Limited license
| + | |
- | The purchase price of this product includes a limited, non-transferable license under U.S. and
| + | |
- | foreign patents owned by BIO-RAD Laboratories, Inc., to use this product. No other license
| + | |
- | under these patents is conveyed expressly or by implication to the purchaser by the purchase
| + | |
- | of this product.
| + | |
- | This product is sold under license from Affibody AB, Sweden.
| + | |
- | The quality system of Finnzymes Oy is certified according to standard SFS-EN ISO9001:2008.
| + | |
- | Phusion® and DyNAzyme™ are trademarks or registered trademarks of Finnzymes Oy,
| + | |
- | a Thermo Fisher Scientific company.
| + | |
- | Affibody® is a registered trademark of Affibody AB, Sweden.
| + | |
- | Version 1.2, April 2010
| + | |
| {{:Team:LMU-Munich/Templates/Page Footer}} | | {{:Team:LMU-Munich/Templates/Page Footer}} |